Neerav Shukla

12.3k total citations
78 papers, 1.7k citations indexed

About

Neerav Shukla is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Hematology. According to data from OpenAlex, Neerav Shukla has authored 78 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 23 papers in Molecular Biology and 22 papers in Hematology. Recurrent topics in Neerav Shukla's work include Acute Myeloid Leukemia Research (17 papers), Sarcoma Diagnosis and Treatment (16 papers) and Acute Lymphoblastic Leukemia research (16 papers). Neerav Shukla is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Sarcoma Diagnosis and Treatment (16 papers) and Acute Lymphoblastic Leukemia research (16 papers). Neerav Shukla collaborates with scholars based in United States, United Kingdom and Italy. Neerav Shukla's co-authors include Marc Ladanyi, Khédoudja Nafa, Jeffrey A. Toretsky, Rachel Kobos, Tsuyoshi Saito, Marick Laé, Makoto Nagai, Peter G. Steinherz, Gaël McGill and Masumi Tsuda and has published in prestigious journals such as Science, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Neerav Shukla

70 papers receiving 1.7k citations

Peers

Countries citing papers authored by Neerav Shukla

Since Specialization

Citations

This map shows the geographic impact of Neerav Shukla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neerav Shukla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neerav Shukla more than expected).

Fields of papers citing papers by Neerav Shukla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neerav Shukla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neerav Shukla. The network helps show where Neerav Shukla may publish in the future.

Co-authorship network of co-authors of Neerav Shukla

This figure shows the co-authorship network connecting the top 25 collaborators of Neerav Shukla. A scholar is included among the top collaborators of Neerav Shukla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neerav Shukla. Neerav Shukla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TAZNI: A phase I/II combination trial of tazemetostat with nivolumab and ipilimumab for children with INI1-negative or SMARCA4-deficient tumors. 2024 ·Journal of Clinical Oncology ·(unknown), Jeffrey T. Czaplinski, (unknown), Suzanne J. Forrest, Neerav Shukla, Stephen C. Mack, Andrew L. Hong, Alex Kentsis, (unknown), (unknown), (unknown), Steven G. DuBois, Wendy B. London, Susan Chi	0
2	Clonal hematopoiesis in survivors of childhood cancer 2023 ·Blood Advances ·Danielle Novetsky Friedman, (unknown), Chaya S. Moskowitz, (unknown), Kimberly L. Turner, Jie Liu, Nancy Bouvier, Michael F. Walsh, Barbara Spitzer, Andrew L. Kung, Michael F. Berger, Megan A. Cooper, Iskra Pusic, Geoffrey L. Uy, Daniel C. Link, Todd E. Druley, Luis A. Díaz, Ross L. Levine, Neerav Shukla, Kelly L. Bolton	13
3	Donor Derived Leukemia in a Recipient of Allogeneic Hematopoietic Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa 2023 ·Transplantation and Cellular Therapy ·Hannah Major-Monfried, Neerav Shukla, Andromachi Scaradavou, Maria Cancio, Andrew C. Harris, Jaap Jan Boelens, Kevin J. Curran, Joseph H. Oved, Jakub Tolar, Nancy A. Kernan, Christen L. Ebens, Barbara Spitzer	0
4	Clonal hematopoiesis in survivors of childhood cancer. 2023 ·Journal of Clinical Oncology ·Danielle Novetsky Friedman, (unknown), Chaya S. Moskowitz, (unknown), Kimberly L. Turner, Jie Liu, Nancy Bouvier, Michael F. Walsh, Barbara Spitzer, Andrew L. Kung, Michael F. Berger, Megan A. Cooper, Iskra Pusic, Geoffrey L. Uy, Daniel C. Link, Todd E. Druley, Luis A. Díaz, Ross L. Levine, Neerav Shukla, Kelly L. Bolton	1
5	Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance 2022 ·JCO Precision Oncology ·Koichi Ogura, Arielle Elkrief, Anita S. Bowman, Richard P. Koche, Elisa de Stanchina, Ryma Benayed, Audrey Mauguen, Marissa S. Mattar, Inna Khodos, Paul A. Meyers, John H. Healey, William D. Tap, Meera Hameed, Ahmet Zehir, Neerav Shukla, Charles L. Sawyers, Rohit Bose, Emily K. Slotkin, Marc Ladanyi	6
6	Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma 2021 ·SHILAP Revista de lepidopterología ·David H. Abramson, Diana Mandelker, Jasmine H. Francis, Ira J. Dunkel, A. Rose Brannon, Ryma Benayed, Michael F. Berger, Maria E. Arcila, Marc Ladanyi, Danielle Novetsky Friedman, Gowtham Jayakumaran, (unknown), (unknown), (unknown), Neerav Shukla, Michael F. Walsh, (unknown), Dana W.Y. Tsui	17
7	Identification of a TP53 Deletion in an Undifferentiated Embryonal Sarcoma of the Liver Provides Clinically Relevant Longitudinal Detection of Circulating Tumor DNA 2021 ·JCO Precision Oncology ·(unknown), (unknown), Nancy Bouvier, (unknown), Jinru Shia, Anita P. Price, Sejal Morjaria, Justin T. Gerstle, Neerav Shukla, Michael V. Ortiz	1
8	Aggressive Hematopoietic Malignancy Characterized by Biallelic Loss of SMARCB1 2020 ·JCO Precision Oncology ·Michael D. Kinnaman, (unknown), Mariko Yabe, Jonathan Powell, Jamal Benhamida, Martin Hasselblatt, Martín Neumann, Christian Vokuhl, Christian Koelsche, Andreas von Deimling, E. Anders Kolb, David B. Solit, Marc Ladanyi, Ahmet Doǧan, Neerav Shukla	1
9	Cell‐free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience 2020 ·Cancer Medicine ·(unknown), Francesco Marass, Julie L. Yang, Caitlin M. Stewart, Dennis Stephens, Juber Patel, Maysun Hasan, Xiaohong Jing, Fanli Meng, (unknown), Kety Huberman, Agnès Viale, Jasmine H. Francis, Michael F. Berger, Neerav Shukla, David H. Abramson, Ira J. Dunkel, Dana W.Y. Tsui	35
10	Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations 2019 ·Clinical Cancer Research ·Yoshiyuki Suehara, Deepu Alex, Anita S. Bowman, Sumit Middha, Ahmet Zehir, Debyani Chakravarty, Lu Wang, George Jour, Khédoudja Nafa, Takuo Hayashi, Achim A. Jungbluth, Denise Frosina, Emily K. Slotkin, Neerav Shukla, Paul A. Meyers, John H. Healey, Meera Hameed, Marc Ladanyi	98
11	Maintenance chemotherapy to reduce the risk of a metachronous Wilms tumor in children with bilateral nephroblastomatosis 2018 ·Pediatric Blood & Cancer ·Michael V. Ortiz, (unknown), Kavitha Ramaswamy, Christopher J. Forlenza, Neerav Shukla, Rachel Kobos, Todd E. Heaton, Michael P. LaQuaglia, Peter G. Steinherz	5
12	A recurrent novel MGA–NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma 2018 ·Molecular Case Studies ·Daniel Diolaiti, Filemon S. Dela Cruz, Gunes Gundem, Nancy Bouvier, (unknown), Yanming Zhang, Alexander J. Chou, Ira J. Dunkel, Rashesh Sanghvi, Minita Shah, Heather Geiger, Sadia Rahman, Vanessa Felice, Kazimierz O. Wrzeszczyński, Robert B. Darnell, Cristina R. Antonescu, Christopher A. French, Elli Papaemmanuil, Andrew L. Kung, Neerav Shukla	39
13	Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis 2017 ·Pediatric Blood & Cancer ·Sara Zarnegar, Benjamin H. Durham, Pallavi Khattar, Neerav Shukla, Ryma Benayed, Mario E. Lacouture, Ehud Lavi, David Lyden, Eli L. Diamond, Ira J. Dunkel, Omar Abdel‐Wahab	17
14	Brentuximab Vedotin Plus Bendamustine Is an Effective Salvage Regimen for Pediatric Patients with Relapsed Hodgkin Lymphoma 2017 ·Blood ·Nitya Gulati, Farid Boulad, Maria Cancio, Kevin J. Curran, Carolyn C. Jackson, Nancy A. Kernan, Andrew L. Kung, Richard J. O’Reilly, Susan E. Prockop, Kavitha Ramaswamy, Andromachi Scaradavou, Barbara Spitzer, Neerav Shukla, Peter G. Steinherz, Christopher J. Forlenza	1
15	High Dose Cyclophosphamide and Pre-Treatment Disease Burden Dictate Response and Survival in a Multicenter Clinical Trial Using CD19-Specific CAR T Cells for Relapsed/Refractory B-ALL 2017 ·Blood ·Kevin J. Curran, Steven Margossian, Nancy A. Kernan, Lewis B. Silverman, Jae H. Park, Craig S. Sauter, Eric L. Smith, Farid Boulad, Maria Cancio, Christopher J. Forlenza, Carolyn C. Jackson, Neerav Shukla, Barbara Spitzer, Susan E. Prockop, Peter G. Steinherz, Andrew L. Kung, Richard J. O’Reilly, Isabelle Rivière, Michel Sadelain, Renier J. Brentjens	1
16	Osteosarcoma With Apparent Ewing Sarcoma Gene Rearrangement 2016 ·Journal of Pediatric Hematology/Oncology ·Melissa Mathias, Alexander J. Chou, Paul A. Meyers, Neerav Shukla, Meera Hameed, Narasimhan P. Agaram, Lu Wang, Michael F. Berger, Michael F. Walsh, Alex Kentsis	2
17	Oncogene Mutation Profiling of Pediatric Solid Tumors Reveals Significant Subsets of Embryonal Rhabdomyosarcoma and Neuroblastoma with Mutated Genes in Growth Signaling Pathways 2011 ·Clinical Cancer Research ·Neerav Shukla, Nabahet Ameur, İsmail Yılmaz, Khédoudja Nafa, (unknown), (unknown), Laetitia Borsu, Frederic G. Barr, Marc Ladanyi	172
18	Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer 2011 ·Science ·David A. Solomon, Taeyeon Kim, Laura A. Díaz-Martínez, (unknown), Abdel Elkahloun, Brent T. Harris, Jeffrey A. Toretsky, Steven A. Rosenberg, Neerav Shukla, Marc Ladanyi, Yardena Samuels, C. David James, Hongtao Yu, Jung-Sik Kim, Todd Waldman	311
19	Novel Markers of Subclinical Disease for Ewing Family Tumors from Gene Expression Profiling 2007 ·Clinical Cancer Research ·Irene Y. Cheung, Yi Feng, (unknown), Neerav Shukla, Paul A. Meyers, Marc Ladanyi, Nai‐Kong V. Cheung	54
20	TFE3 Fusions Activate MET Signaling by Transcriptional Up-regulation, Defining Another Class of Tumors as Candidates for Therapeutic MET Inhibition 2007 ·Cancer Research ·Masumi Tsuda, Ian J. Davis, Pedram Argani, Neerav Shukla, Gaël McGill, Makoto Nagai, Tsuyoshi Saito, Marick Laé, David E. Fisher, Marc Ladanyi	217

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact